|
SNTB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.496600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.856800E-01 |
| Normal-vs-Stage2 |
5.231200E-01 |
| Normal-vs-Stage3 |
3.745400E-01 |
| Normal-vs-Stage4 |
4.699800E-01 |
| Stage1-vs-Stage2 |
5.644000E-01 |
| Stage1-vs-Stage3 |
3.726800E-01 |
| Stage1-vs-Stage4 |
5.451000E-01 |
| Stage2-vs-Stage3 |
6.738400E-01 |
| Stage2-vs-Stage4 |
3.103400E-01 |
| Stage3-vs-Stage4 |
2.310800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.134800E-01 |
| Normal-vs-AfricanAmerican |
9.804000E-01 |
| Normal-vs-Asian |
5.572600E-01 |
| Caucasian-vs-AfricanAmerican |
7.300000E-01 |
| Caucasian-vs-Asian |
5.814800E-01 |
| AfricanAmerican-vs-Asian |
5.601200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.700400E-01 |
| Normal-vs-Female |
6.163400E-01 |
| Male-vs-Female |
9.707600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.858400E-01 |
| Normal-vs-Extreme_Weight |
3.061200E-01 |
| Normal-vs-Obese |
3.275800E-01 |
| Normal-vs-Extreme_Obese |
9.812600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.557400E-01 |
| Normal_Weight-vs-Obese |
9.043500E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.889600E-01 |
| Extreme_Weight-vs-Obese |
7.415600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.431200E-01 |
| Obese-vs-Extreme_Obese |
6.836600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.283400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.605600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.154600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.739200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.571400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.872400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.710200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.838000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.650800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.799400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.635800E-01 |
| Normal-VS-Type2 PRCC |
7.671000E-01 |
| Normal-VS-KIRP CIMP |
3.613000E-01 |
| Normal-VS-Unclassified PRCC |
1.105970E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.629200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.224200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.199030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.711200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.835400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.426600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.162800E-01 |
| Normal-vs-N1 |
6.754800E-01 |
| Normal-vs-N2 |
3.080700E-03 |
| N0-vs-N1 |
8.434800E-01 |
| N0-vs-N2 |
4.721300E-03 |
| N1-vs-N2 |
3.273800E-02 |
|
|
